Japan’s Ministry of Health, Labor and Welfare has approved biotechnology manufacturer CSL and Arcturus Therapeutics’ new Covid-19 vaccine against the JN.1 strain of the disease. The ministry approved for sale the two companies’ ‘updated self-amplifying mRNA Covid-19 vaccine for protection against JN.1 Strain’, to be distributed in Japan by Meiji Seika Pharma. According to CSL…
IDT Australia secures Sanofi contract Pharmaceutical development company IDT Australia has secured a follow on contract with pharma giant Sanofi Australia for preclinical formulation, development and manufacture of Sanofi’s messenger RNA (mRNA). The contract, worth up to $4 million, continues the company’s advancement of mRNA-based vaccine formulation, development and manufacture at IDT’s aseptic sterile injectables…
Australia’s most successful manufacturer, biotechnology company CSL today reported net profit after tax of $2.64 billion for the 12 months ended 30 June 2024, up 25 percent on a constant currency basis. Net profit after tax (NPATA) was $2.91 billion, up 15 percent on revenue up 11 percent to $14.8 billion. CSL’s Chief Executive Officer…
Fleet on hiring spree Small satellite business Fleet Space Technologies is hiring for 11 positions, the company’s co-founder and CEO announced on Monday. In a statement on Linkedin, Flavia Tata Nardini posted about the positions vacant, listing Key Account Executive – Salt Lakes (US)m Senior Sales Executive – Macquarie Arc (AUS), Sales Engineer (APAC), Data…
More rocket launches planned for Koonibba Test Range German rocket manufacturer Hyimpulse is negotiating further space launches from Southern Launch’s South Australian launch facilities following the successful launch its SL1 sub-orbital vehicle from the Koonibba Test Range near Ceduna, SA (pictured). The launch tested Hyimpulse’s novel propulsion technology. The company now plans further launches from…
Drug development company IDT Australia and pharmaceutical business Sanofi have signed an agreement for the good manufacturing practice (cGMP) manufacture of Sanofi’s mRNA vaccines now under development. The partners will collaborate to advance mRNA-based vaccine formulation, development and manufacture at IDT’s aseptic sterile injectables filling facilities in Melbourne (pictured) in volumes needed for clinical trials…
Animal health company Zoetis has bought a 21-acre manufacturing site in Melbourne to significantly expand its operations and increase capabilities to manufacture vaccines for sheep, cattle, dogs, cats and horses. The company which produces 130 million doses of vaccines for companion animals and livestock in Australia each year, said the expansion would support development of…
Biotechnology giant CSL has reported net profit after tax for the six months ended December 31 of $1.9 billion, up 20 percent on the previous corresponding period. Underlying net profit was $2.02, set on revenue up 11 percent to $8.05 billion. CSL CEO and Managing Director Dr Paul McKenzie said: “Our strong first half result…
By Brent Balinski Nobody is exactly keen on getting a needle, and getting rid of them is an old idea. Some articles trace an alternative, microarray patches, back to the 1970s, but today we still generally get our vaccines and various other drugs the old way – jabbed into our muscles. Ideas are easy, but…
Private investment firm, Bridgewest Group has expanded its pharmaceuticals portfolio, announcing the purchase of the sterile injectable manufacturing facility of Pfizer (Perth) Pty Ltd, a subsidiary of Pfizer, Inc. The cGMP manufacturing facility, located in Bentley, Perth is a diverse sterile injectable manufacturing facility, approved to supply drug products in over 90 countries with approvals…
